Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
21 Jan 2017 | 8:40 AM
Research Report
Daily

Equity Research Report: Religare Morning Digest

Despite strong closing in the end; market breadth was mix, indicating indecisiveness among traders. We reiterate, our bias is on the down side till Nifty index is upholding below 7350 mark.
18 Feb 2016 | 07:00 AM

    Religare Morning Digest – Highlights for today
 
Market Outlook for the day -Despite strong closing in the end; market breadth was mix, indicating indecisiveness among traders. We reiterate, our bias is on the down side till Nifty index is upholding below 7350 mark.
Key Indices – Levels to watch out for the day
INDEX (Spot) RESISTANCE 2 RESISTANCE 1 LTP SUPPORT 1 SUPPORT 2
SENSEX 24820 23600 23381.87 23150 22980
NIFTY 7250 7175 7108.45 7035 6980
NIFTYBANK 14600 14400 14119.85 13980 13800
NIFTYIT 10800 10650 10502.45 10400 10280
News -
  • Glenmark Pharmaceuticals US unit has been granted tentative approval by the United States Food & Drug Administration (USFDA) for its Azelaic Acid Gel, 15%, the generic version of Finacea Topical Gel, 15% of Bayer Healthcare.
  • TCS announced launch of Digital Reimagination Studio in Silicon Valley, designed to help customers and partners rapidly ideate bold new innovations and build industry changing concepts.
  • Bank of India said that Standard & Poor's (S&P) Ratings revised its outlook on the bank to 'negative' from 'stable'.
 
    Trading/ Investment Ideas
Technical Calls
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target Time
Frame
MARICO BUY 227.30 226-228 218 248 3-5 Days
GAIL SELL FEB FUT 324.20 328-330 341 305 3-5 Days
 
Derivatives Call
Company
Name
Recommendation CMP Initiation
Price
Stop
loss
Target Time
Frame
SUNPHARMA BUY 860 CE 16.50 12-13 7 22 3-5 Days
 
Fundamental Picks for delivery (9 Months - 1 Year)
Company
Name
Recommendation CMP Initiation
Range
Target
SMLISUZU BUY 763.85 869 1150
JYOTHYLAB BUY 271.00 272.40 330
SUPREMEIND BUY 686.30 699.30 840
Note – For our running recommendations and past performance, please click here
Research Disclaimer
Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.